Regencell Bioscience (RGC) EPS (2020 - 2025)
Regencell Bioscience (RGC) EPS from Jun 30, 2020 to Jun 30, 2025. The TTM Regencell Bioscience (RGC) EPS is -$0.00724. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Regencell Bioscience (RGC) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -16.74% |
| 3 Years | -21.67% |
| 5 Years | +27.70% |
| All Time | +27.71% |
Annual EPS change of Regencell Bioscience (RGC)
| Year | EPS | Change |
|---|---|---|
| 2025 | -$0.00724 | -16.74% |
| 2024 | -$0.00870 | -26.75% |
| 2023 | -$0.01 | -21.21% |
| 2022 | -$0.02 | +324.08% |
| 2021 | -$0.00355 | +66.67% |
| 2020 | -$0.00213 | N/A |
Comparison Regencell Bioscience (RGC) five years EPS CAGR with competitors
Regencell Bioscience (RGC) five years EPS CAGR is 27.66%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 101.37% | +266.50% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.58% | +3.33% |
| UTHR | United Therapeutics Corp | 26.56% | -3.98% |
| ANIP | ANI Pharmaceuticals Inc | 25.74% | -6.93% |
| LFCR | Lifecore Biomedical Inc | 16.09% | -41.82% |
| PAHC | Phibro Animal Health Corp - Class A | 15.27% | -44.78% |
| ZTS | Zoetis Inc - Class A | 10.56% | -61.83% |
| NBIX | Neurocrine Biosciences Inc | 9.25% | -66.55% |
| PBH | Prestige Consumer Healthcare Inc | 8.18% | -70.42% |
| BCRX | Biocryst Pharmaceuticals Inc | 6.24% | -77.44% |
| BHC | Bausch Health Companies Inc | 2.51% | -90.92% |
| RDY | Dr. Reddy`s Laboratories Ltd | 2.45% | -91.15% |
| YCBD | cbdMD Inc | 1.50% | -94.58% |